Obesity and psychiatric disorders: Commonalities in dysregulated biological pathways and their implications for treatment

[1]  P. Masand,et al.  Oxidative/nitrosative stress and antidepressants: Targets for novel antidepressants , 2013, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[2]  T. Lambert,et al.  Obstructive sleep apnoea and schizophrenia--a research agenda. , 2013, Sleep medicine reviews.

[3]  Eileen Luders,et al.  Relationships between gray matter, body mass index, and waist circumference in healthy adults , 2013, Human brain mapping.

[4]  P. Drummond,et al.  A review of lifestyle factors that contribute to important pathways associated with major depression: diet, sleep and exercise. , 2013, Journal of affective disorders.

[5]  N. Wray,et al.  The neuroprogressive nature of major depressive disorder: pathways to disease evolution and resistance, and therapeutic implications , 2013, Molecular Psychiatry.

[6]  M. Maes,et al.  Exercising the worry away: How inflammation, oxidative and nitrogen stress mediates the beneficial effect of physical activity on anxiety disorder symptoms and behaviours , 2013, Neuroscience & Biobehavioral Reviews.

[7]  M. Berk,et al.  Schizophrenia is primed for an increased expression of depression through activation of immuno-inflammatory, oxidative and nitrosative stress, and tryptophan catabolite pathways , 2013, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[8]  A. Altamura,et al.  Neurodevelopment and inflammatory patterns in schizophrenia in relation to pathophysiology , 2013, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[9]  M. Berk,et al.  Immuno-inflammatory, oxidative and nitrosative stress, and neuroprogressive pathways in the etiology, course and treatment of schizophrenia , 2013, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[10]  M. Berk,et al.  Putative neuroprotective agents in neuropsychiatric disorders , 2013, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[11]  Michael Maes,et al.  Schizophrenia: Linking prenatal infection to cytokines, the tryptophan catabolite (TRYCAT) pathway, NMDA receptor hypofunction, neurodevelopment and neuroprogression , 2013, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[12]  D. Müller,et al.  The pharmacogenetics of antipsychotic-induced adverse events , 2013, Current opinion in psychiatry.

[13]  A. Eynard,et al.  Overweight and obesity: a review of their relationship to metabolic syndrome, cardiovascular disease, and cancer in South America. , 2013, Nutrition reviews.

[14]  E. Mannucci,et al.  Depression as a risk factor for diabetes: a meta-analysis of longitudinal studies. , 2013, The Journal of clinical psychiatry.

[15]  K. Kotzampassi,et al.  The Impact of Weight Loss on Depression Status in Obese Individuals Subjected to Intragastric Balloon Treatment , 2013, Obesity Surgery.

[16]  F. Zitman,et al.  Longitudinal Relationship of Depressive and Anxiety Symptoms With Dyslipidemia and Abdominal Obesity , 2013, Psychosomatic medicine.

[17]  A. Lorenzo,et al.  Antioxidants as Antidepressants , 2012, CNS Drugs.

[18]  F. Velluzzi,et al.  Mental disorders in patients with metabolic syndrome. The key role of central obesity , 2012, Eating and Weight Disorders - Studies on Anorexia, Bulimia and Obesity.

[19]  A Villringer,et al.  Overweight and obesity are associated with neuronal injury in the human cerebellum and hippocampus in young adults: a combined MRI, serum marker and gene expression study , 2012, Translational Psychiatry.

[20]  A. Mykletun,et al.  Moving towards a population health approach to the primary prevention of common mental disorders , 2012, BMC Medicine.

[21]  K. Chou.  Childhood sexual abuse and psychiatric disorders in middle-aged and older adults: evidence from the 2007 Adult Psychiatric Morbidity Survey. , 2012, The Journal of clinical psychiatry.

[22]  P. Drummond,et al.  Multiple antidepressant potential modes of action of curcumin: a review of its anti-inflammatory, monoaminergic, antioxidant, immune-modulating and neuroprotective effects , 2012, Journal of psychopharmacology.

[23]  A. Convit,et al.  Obesity and Metabolic Syndrome and Functional and Structural Brain Impairments in Adolescence , 2012, Pediatrics.

[24]  J. Laugharne,et al.  Obesity, cardiovascular disease and type 2 diabetes in people with a mental illness: a need for primary health care. , 2012, Australian journal of primary health.

[25]  J. Palmer,et al.  Child and Adolescent Abuse in Relation to Obesity in Adulthood: The Black Women’s Health Study , 2012, Pediatrics.

[26]  A. Convit,et al.  Effectiveness of a Cognitive Behavioral Weight Management Intervention in Obese Patients With Psychotic Disorders Compared to Patients With Nonpsychotic Disorders or No Psychiatric Disorders: Results From a 12-month, Real-World Study , 2012, Journal of clinical psychopharmacology.

[27]  M. Savu,et al.  Five-Year Changes in Psychiatric Treatment Status and Weight-Related Comorbidities Following Bariatric Surgery in a Veteran Population , 2012, Obesity Surgery.

[28]  C. Goss,et al.  Health promotion lifestyle interventions for weight management in psychosis: a systematic review and meta-analysis of randomised controlled trials , 2012, BMC Psychiatry.

[29]  Randy L. Moore,et al.  Biological perspectives: the role of glutamate in schizophrenia and its treatment. , 2012, Perspectives in psychiatric care.

[30]  V. Taylor,et al.  Changes in Body Weight and Psychotropic Drugs: A Systematic Synthesis of the Literature , 2012, PloS one.

[31]  M. Kivimäki,et al.  Bidirectional association between physical activity and symptoms of anxiety and depression: the Whitehall II study , 2012, European Journal of Epidemiology.

[32]  C. Ulrich,et al.  Effects of a caloric restriction weight loss diet and exercise on inflammatory biomarkers in overweight/obese postmenopausal women: a randomized controlled trial. , 2012, Cancer research.

[33]  Jong-deuk Baek,et al.  Physical activity status in adults with depression in the National Health and Nutrition Examination Survey, 2005-2006. , 2012, Public health nursing.

[34]  R. Tabarés-Seisdedos,et al.  The Clinical Implications Of Cognitive Impairment and Allostatic Load in Bipolar Disorder , 2013, European Psychiatry.

[35]  M. Pérez-Paredes,et al.  Obesity and Inflammation: Change in Adiponectin, C-Reactive Protein, Tumour Necrosis Factor-Alpha and Interleukin-6 After Bariatric Surgery , 2012, Obesity Surgery.

[36]  B. Leonard,et al.  The metabolic syndrome in schizophrenia: is inflammation a contributing cause? , 2012, Journal of psychopharmacology.

[37]  T. Wadden,et al.  One‐Year Changes in Symptoms of Depression and Weight in Overweight/Obese Individuals With Type 2 Diabetes in the Look AHEAD Study , 2012, Obesity.

[38]  A. Myint.  Kynurenines: from the perspective of major psychiatric disorders , 2012, The FEBS journal.

[39]  C. Mobbs,et al.  Hypothalamic BDNF and obesity: found in translation , 2012, Nature Medicine.

[40]  C. Jack,et al.  Modifiable factors that alter the size of the hippocampus with ageing , 2012, Nature Reviews Neurology.

[41]  P. Das,et al.  The science and practice of lithium therapy , 2012, The Australian and New Zealand journal of psychiatry.

[42]  M. Maes,et al.  Mechanistic explanations how cell-mediated immune activation, inflammation and oxidative and nitrosative stress pathways and their sequels and concomitants play a role in the pathophysiology of unipolar depression , 2012, Neuroscience & Biobehavioral Reviews.

[43]  M. Schwarz,et al.  The role of the kynurenine metabolism in major depression , 2012, Journal of Neural Transmission.

[44]  M. Berk,et al.  N-acetylcysteine for major depressive episodes in bipolar disorder. , 2011, Revista brasileira de psiquiatria.

[45]  T. Stijnen,et al.  Immediate and long-term effects of addition of exercise to a 16-week very low calorie diet on low-grade inflammation in obese, insulin-dependent type 2 diabetic patients. , 2011, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[46]  T. Wadden,et al.  Intentional weight loss and changes in symptoms of depression: a systematic review and meta-analysis , 2011, International Journal of Obesity.

[47]  J. Tucker,et al.  Television Viewing and Obesity in 300 Women: Evaluation of the Pathways of Energy Intake and Physical Activity , 2011, Obesity.

[48]  J. de Irala,et al.  Fast-food and commercial baked goods consumption and the risk of depression , 2011, Public Health Nutrition.

[49]  T. Hartman,et al.  Food Intake Patterns and Body Mass Index in Older Adults: A Review of the Epidemiological Evidence , 2011, Journal of nutrition in gerontology and geriatrics.

[50]  C. Blanco,et al.  The burden of obesity among adults with bipolar disorder in the United States , 2011, Bipolar disorders.

[51]  S. Kennedy,et al.  Mood Disorders and Obesity: Understanding Inflammation as a Pathophysiological Nexus , 2011, NeuroMolecular Medicine.

[52]  T. Wadden,et al.  Treatment of Comorbid Obesity and Major Depressive Disorder: A Prospective Pilot Study for their Combined Treatment , 2011, Journal of obesity.

[53]  C. Billington,et al.  The lighter side of BDNF. , 2011, American journal of physiology. Regulatory, integrative and comparative physiology.

[54]  B. Leonard,et al.  The new ‘5-HT’ hypothesis of depression: Cell-mediated immune activation induces indoleamine 2,3-dioxygenase, which leads to lower plasma tryptophan and an increased synthesis of detrimental tryptophan catabolites (TRYCATs), both of which contribute to the onset of depression , 2011, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[55]  K. Sanderson,et al.  Overweight and Obesity in Childhood and Risk of Mental Disorder: a 20-Year Cohort Study , 2011, The Australian and New Zealand journal of psychiatry.

[56]  S. Gautam,et al.  Drug-emergent metabolic syndrome in patients with schizophrenia receiving atypical (second-generation) antipsychotics , 2011, Indian journal of psychiatry.

[57]  R. Dantzer,et al.  Inflammation-associated depression: From serotonin to kynurenine , 2011, Psychoneuroendocrinology.

[58]  S. Tangye,et al.  Inflammatory Mechanisms in Obesity , 2013 .

[59]  W. Steinmann,et al.  Bariatric Surgery: 1-Year Weight Loss Outcomes in Patients with Bipolar and Other Psychiatric Disorders , 2011, Obesity surgery.

[60]  C. Rock,et al.  Effects of a Weight Loss Intervention on Body Mass, Fitness, and Inflammatory Biomarkers in Overweight or Obese Breast Cancer Survivors , 2011, International journal of behavioral medicine.

[61]  J. Linde,et al.  A Randomized Controlled Trial of Behavioral Weight Loss Treatment Versus Combined Weight Loss/Depression Treatment Among Women with Comorbid Obesity and Depression , 2011, Annals of behavioral medicine : a publication of the Society of Behavioral Medicine.

[62]  M. Berk,et al.  eview athways underlying neuroprogression in bipolar disorder : Focus on nflammation , oxidative stress and neurotrophic factors , 2010 .

[63]  J. Polimeni,et al.  Antidepressant Drug Therapy Does Not Affect Weight Loss One Year after Gastric Bypass Surgery , 2011, Obesity surgery.

[64]  A. Awad,et al.  Curcumin and obesity: evidence and mechanisms. , 2010, Nutrition reviews.

[65]  A. Dalcin,et al.  A behavioral weight loss intervention for persons with serious mental illness in psychiatric rehabilitation centers , 2010, International Journal of Obesity.

[66]  John M. Davis,et al.  Head-to-head comparisons of metabolic side effects of second generation antipsychotics in the treatment of schizophrenia: A systematic review and meta-analysis , 2010, Schizophrenia Research.

[67]  A. Serretti,et al.  Antidepressants and body weight: a comprehensive review and meta-analysis. , 2010, The Journal of clinical psychiatry.

[68]  R. Shelton,et al.  Eating ourselves to death (and despair): The contribution of adiposity and inflammation to depression , 2010, Progress in Neurobiology.

[69]  N. Pivac,et al.  Catechol-O-methyl transferase and schizophrenia. , 2010, Psychiatria Danubina.

[70]  T. S. Fröde,et al.  Roux-en-Y Bypass Gastroplasty: Markers of Oxidative Stress 6 Months After Surgery , 2010, Obesity surgery.

[71]  J. Calabrese,et al.  Medical comorbidity in bipolar disorder: relationship between illnesses of the endocrine/metabolic system and treatment outcome. , 2010, Bipolar disorders.

[72]  R. Ross,et al.  Exercise without weight loss does not reduce C-reactive protein: the INFLAME study. , 2010, Medicine and science in sports and exercise.

[73]  C. Correll,et al.  Effectiveness of Medications Used to Attenuate Antipsychotic-Related Weight Gain and Metabolic Abnormalities: A Systematic Review and Meta-Analysis , 2010, Neuropsychopharmacology.

[74]  Theo Stijnen,et al.  Overweight, obesity, and depression: a systematic review and meta-analysis of longitudinal studies. , 2010, Archives of general psychiatry.

[75]  Xu-Feng Huang,et al.  The role of histaminergic H1 and H3 receptors in food intake: A mechanism for atypical antipsychotic-induced weight gain? , 2010, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[76]  Carrie R Houts,et al.  Stress, Inflammation, and Yoga Practice , 2010, Psychosomatic medicine.

[77]  G. Lorenzo,et al.  Early trauma and adult obesity: Is psychological dysfunction the mediating mechanism? , 2009, Physiology & Behavior.

[78]  A. Young,et al.  The role of dopamine in bipolar disorder. , 2009, Bipolar disorders.

[79]  M. Rietschel,et al.  Body weight as a predictor of antidepressant efficacy in the GENDEP project. , 2009, Journal of affective disorders.

[80]  M. Delgado-Rodríguez,et al.  Association of the Mediterranean dietary pattern with the incidence of depression: the Seguimiento Universidad de Navarra/University of Navarra follow-up (SUN) cohort. , 2009, Archives of general psychiatry.

[81]  P. Doraiswamy,et al.  Does Meditation Enhance Cognition and Brain Plasticity? , 2009, Annals of the New York Academy of Sciences.

[82]  R. Reeves,et al.  Efficacy of behavioural interventions in managing atypical antipsychotic weight gain , 2009, Obesity reviews : an official journal of the International Association for the Study of Obesity.

[83]  A. Toga,et al.  Brain Structure and Obesity , 2009, NeuroImage.

[84]  S. McElroy.  Obesity in patients with severe mental illness: overview and management. , 2009, The Journal of clinical psychiatry.

[85]  R. Yoshimura,et al.  Higher plasma interleukin-6 (IL-6) level is associated with SSRI- or SNRI-refractory depression , 2009, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[86]  W. Riley,et al.  Obesity among those with mental disorders: a National Institute of Mental Health meeting report. , 2009, American journal of preventive medicine.

[87]  A. Mykletun,et al.  The relationship between abdominal fat, obesity, and common mental disorders: results from the HUNT study. , 2009, Journal of psychosomatic research.

[88]  M. Rogge.  The Role of Impaired Mitochondrial Lipid Oxidation in Obesity , 2009, Biological research for nursing.

[89]  P. Seeman.  Glutamate and dopamine components in schizophrenia. , 2009, Journal of psychiatry & neuroscience : JPN.

[90]  N. Volkow,et al.  Imaging of Brain Dopamine Pathways: Implications for Understanding Obesity , 2009, Journal of addiction medicine.

[91]  J. Linde,et al.  Reported food choices in older women in relation to body mass index and depressive symptoms , 2009, Appetite.

[92]  Yu-Shu Huang,et al.  Effects of a 10‐week weight control program on obese patients with schizophrenia or schizoaffective disorder: A 12‐month follow up , 2009, Psychiatry and clinical neurosciences.

[93]  G. Brinkworth,et al.  Effect of caloric restriction with and without exercise training on oxidative stress and endothelial function in obese subjects with type 2 diabetes , 2008, Diabetes, obesity & metabolism.

[94]  R. Rosenheck,et al.  Fast food consumption and increased caloric intake: a systematic review of a trajectory towards weight gain and obesity risk , 2008, Obesity reviews : an official journal of the International Association for the Study of Obesity.

[95]  P. Cowen.  Serotonin and depression: pathophysiological mechanism or marketing myth? , 2008, Trends in pharmacological sciences.

[96]  G. Maina,et al.  Prevalence and correlates of overweight in drug-naïve patients with bipolar disorder. , 2008, Journal of affective disorders.

[97]  Norbert Müller,et al.  COX-2 inhibition in schizophrenia and major depression. , 2008, Current pharmaceutical design.

[98]  Eosu Kim,et al.  A Preliminary Investigation of &agr;-Lipoic Acid Treatment of Antipsychotic Drug-Induced Weight Gain in Patients With Schizophrenia , 2008, Journal of clinical psychopharmacology.

[99]  N. Petry,et al.  Overweight and Obesity Are Associated With Psychiatric Disorders: Results From the National Epidemiologic Survey on Alcohol and Related Conditions , 2008, Psychosomatic medicine.

[100]  E. Maron,et al.  Pro-inflammatory cytokines and treatment response to escitaloprsam in major depressive disorder , 2008, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[101]  A. Rissanen,et al.  Weight loss larger than 10% is needed for general improvement of levels of circulating adiponectin and markers of inflammation in obese subjects: a 3-year weight loss study. , 2008, European journal of endocrinology.

[102]  Hiroshi Fukuda,et al.  Relationship Between Body Mass Index and Gray Matter Volume in 1,428 Healthy Individuals , 2008, Obesity.

[103]  M. Covas,et al.  Association of fast food consumption with energy intake, diet quality, body mass index and the risk of obesity in a representative Mediterranean population , 2007, British Journal of Nutrition.

[104]  H. Vincent,et al.  Oxidative stress and potential interventions to reduce oxidative stress in overweight and obesity , 2007, Diabetes, obesity & metabolism.

[105]  J. Kennedy,et al.  Association of the HTR2C gene and antipsychotic induced weight gain: a meta-analysis. , 2007, The international journal of neuropsychopharmacology.

[106]  F. Holsboer,et al.  Overweight and Obesity Affect Treatment Response in Major Depression , 2007, Biological Psychiatry.

[107]  J. LeCheminant,et al.  A Prospective Study of Physical Activity Intensity and Change in Adiposity in Middle-Aged Women , 2007, American journal of health promotion : AJHP.

[108]  P. Scully,et al.  Plasma cytokine profiles in depressed patients who fail to respond to selective serotonin reuptake inhibitor therapy. , 2007, Journal of psychiatric research.

[109]  R. Holt,et al.  Long‐term maintenance of weight loss in patients with severe mental illness through a behavioural treatment programme in the UK , 2007, Acta psychiatrica Scandinavica.

[110]  W. Brown,et al.  BMI, sex, and antidepressant response. , 2007, Journal of affective disorders.

[111]  D. Fuchs,et al.  Chronic immune activation underlies morbid obesity: is IDO a key player? , 2007, Current drug metabolism.

[112]  P. Alpert,et al.  Promising New Causal Explanations for Obesity and Obesity-Related Diseases , 2007, Biological research for nursing.

[113]  J. C. E. Silva.  Sleep disorders in psychiatry , 2006 .

[114]  M. Bougoulia,et al.  Plasma interleukin-6 levels, glutathione peroxidase and isoprostane in obese women before and after weight loss. Association with cardiovascular risk factors. , 2006, Hormones.

[115]  E. Gordon,et al.  Exposure to early life trauma is associated with adult obesity , 2006, Psychiatry Research.

[116]  Dan Mungas,et al.  Central obesity and the aging brain. , 2005, Archives of neurology.

[117]  F. Dickerson,et al.  Health status of individuals with serious mental illness. , 2005, Schizophrenia bulletin.

[118]  H. Kelestimur,et al.  Exercise training as an adjunct to orlistat therapy reduces oxidative stress in obese subjects. , 2005, The Tohoku journal of experimental medicine.

[119]  G. Reynolds,et al.  Polymorphisms of the 5-HT2C receptor and leptin genes are associated with antipsychotic drug-induced weight gain in Caucasian subjects with a first-episode psychosis , 2005, Pharmacogenetics and genomics.

[120]  A. Ferenczi,et al.  Obesity and Cortisol Status , 2005, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[121]  M. Fava,et al.  Obesity among outpatients with major depressive disorder. , 2005, The international journal of neuropsychopharmacology.

[122]  J. Hebebrand,et al.  Clozapine: weight gain in a pair of monozygotic twins concordant for schizophrenia and mild mental retardation , 2005, Psychiatry Research.

[123]  Morihiro Matsuda,et al.  Increased oxidative stress in obesity and its impact on metabolic syndrome. , 2004, The Journal of clinical investigation.

[124]  S. Minsky,et al.  Managing atypical antipsychotic-associated weight gain: 12-month data on a multimodal weight control program. , 2004, The Journal of clinical psychiatry.

[125]  E. Bleecker,et al.  Diet-induced weight loss, exercise, and chronic inflammation in older, obese adults: a randomized controlled clinical trial. , 2004, The American journal of clinical nutrition.

[126]  Anissa Abi-Dargham,et al.  Do we still believe in the dopamine hypothesis? New data bring new evidence. , 2004, The international journal of neuropsychopharmacology.

[127]  D. Ford,et al.  Prevalence and Correlates of Obesity in a Community Sample of Individuals with Severe and Persistent Mental Illness , 2003, The Journal of nervous and mental disease.

[128]  S. Minsky,et al.  A program for managing weight gain associated with atypical antipsychotics. , 2003, Psychiatric services.

[129]  L. Breum,et al.  Twenty-four-hour plasma tryptophan concentrations and ratios are below normal in obese subjects and are not normalized by substantial weight reduction. , 2003, The American journal of clinical nutrition.

[130]  N. Breslau.  Epidemiologic Studies of Trauma, Posttraumatic Stress Disorder, and other Psychiatric Disorders , 2002, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

[131]  F. Svec,et al.  Levels of Hypothalamic Neurotransmitters in Lean and Obese Zucker Rats , 2002, Nutritional neuroscience.

[132]  U. Das.  Is obesity an inflammatory condition? , 2001, Nutrition.

[133]  M. Duclos,et al.  Fat distribution in obese women is associated with subtle alterations of the hypothalamic–pituitary–adrenal axis activity and sensitivity to glucocorticoids , 2001, Clinical endocrinology.

[134]  Jean Logan,et al.  Brain dopamine and obesity , 2001, The Lancet.

[135]  M. Collin,et al.  Decreased 5-HT transporter mRNA in neurons of the dorsal raphe nucleus and behavioral depression in the obese leptin-deficient ob/ob mouse. , 2000, Brain research. Molecular brain research.

[136]  C. Guilleminault,et al.  Prevalence of insomnia in a survey of 12 778 adults in France , 2000, Journal of sleep research.

[137]  R. Floyd.  Antioxidants, oxidative stress, and degenerative neurological disorders. , 1999, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[138]  Tord Høivik,et al.  A program , 1971 .

[139]  C. Tek,et al.  An open-label pilot trial of alpha-lipoic acid for weight loss in patients with schizophrenia without diabetes. , 2015, Clinical schizophrenia & related psychoses.

[140]  D. F. Drake,et al.  A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers. , 2013, JAMA psychiatry.

[141]  S. Karasu.  Of mind and matter: psychological dimensions in obesity. , 2012, American journal of psychotherapy.

[142]  S. Salim,et al.  Inflammation in anxiety. , 2012, Advances in protein chemistry and structural biology.

[143]  J. Chudek,et al.  Changes of systemic microinflammation after weight loss and regain - a five-year follow up study. , 2012, Endokrynologia Polska.

[144]  N. Steinle,et al.  Genetics of eating behavior: established and emerging concepts. , 2011, Nutrition reviews.

[145]  Lisa Goehler,et al.  Depression's multiple comorbidities explained by (neuro)inflammatory and oxidative & nitrosative stress pathways. , 2011, Neuro endocrinology letters.

[146]  M. Macek,et al.  The serotonin transporter gene (5-HTT) variant and psychiatric disorders: review of current literature. , 2010, Neuro endocrinology letters.

[147]  E. Maron,et al.  Pro-inflammatory cytokines and treatment response to escitalopram in major depressive disorder. , 2008, Progress in neuro-psychopharmacology & biological psychiatry.

[148]  A. Krystal,et al.  Sleep disturbance in psychiatric disorders: effects on function and quality of life in mood disorders, alcoholism, and schizophrenia. , 2008, Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists.

[149]  Del D. Miller,et al.  Leptin and leptin receptor gene polymorphisms and increases in body mass index (BMI) from olanzapine treatment in persons with schizophrenia. , 2007, Psychopharmacology bulletin.

[150]  J. Newcomer.  Second-Generation (Atypical) Antipsychotics and Metabolic Effects , 2005, CNS drugs.

[151]  R. Berkowitz,et al.  Obesity, psychiatric status, and psychiatric medications. , 2005, The Psychiatric clinics of North America.

[152]  F. Kulhanek,et al.  [Schizophrenia and its treatment]. , 1979, Actas luso-espanolas de neurologia, psiquiatria y ciencias afines.